Aardvark Therapeutics Financial Statements 2022-2025 | AARD

Fifteen years of historical annual and quarterly income statements for Aardvark Therapeutics (AARD).

Annual Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
TTM202420232022
$0.00$0$0$0
$0.00$0$0$0
$0.00$0$0$0
$8.96$17.36$4.48$7.17
$3.58$5.31$2.17$2.70
$-0.10$-0.12$-0.76$-1.49
$0.00$0$0$0
$-12.64$-22.79$-7.42$-11.36
$1.15$2.20$0.21$-2.20
$-11.49$-20.59$-7.21$-13.56
$0.00$0$0$0
$-11.49$-20.59$-7.21$-13.56
$0.00$0$0$0
$-11.49$-20.59$-7.21$-13.56
$0.00$0$0$0
$-11.49$-20.59$-7.21$-13.56
$-12.72$-22.87$-7.42$-11.25
$-12.64$-22.79$-7.42$-11.36
$-1.26$-5.15$-1.82$-3.49
$-1.26$-5.15$-1.82$-3.49

Quarterly Data | Millions of US $ except per share data

Metric Name
Revenue
Cost Of Goods Sold
Gross Profit
Research And Development Expenses
SG&A Expenses
Other Operating Income Or Expenses
Operating Expenses
Operating Income
Total Non-Operating Income/Expense
Pre-Tax Income
Income Taxes
Income After Taxes
Other Income
Income From Continuous Operations
Income From Discontinued Operations
Net Income
EBITDA
EBIT
Basic EPS
EPS - Earnings Per Share
2025-03-312024-12-312024-03-312023-12-312022-12-31
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$7.76$0$1.21$0$0
$2.72$0$0.86$0$0
$0$0$-0.10$0$0
$0$0$0$0$0
$-10.47$0$-2.17$0$0
$1.16$0$-0.01$0$0
$-9.31$0$-2.18$0$0
$0$0$0$0$0
$-9.31$0$-2.18$0$0
$0$0$0$0$0
$-9.31$0$-2.18$0$0
$0$0$0$0$0
$-9.31$0$-2.18$0$0
$-10.55$0$-2.17$0$0
$-10.47$0$-2.17$0$0
$-0.71$0$-0.55$0$0
$-0.71$0.00$-0.55$0.00$0.00